Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
13,080
-80 (-0.61%)
Last updated: Sep 9, 2025, 9:11 AM KST
KRX:007570 Market Cap
KRX:007570 has a market cap or net worth of 235.89 billion as of September 8, 2025. Its market cap has decreased by -11.13% in one year.
Market Cap
235.89B
Enterprise Value
346.54B
Revenue
276.35B
Ranking
n/a
PE Ratio
21.83
Stock Price
13,080.00
Market Cap Chart
Since January 29, 1993, KRX:007570's market cap has increased from 50.67B to 235.89B, an increase of 365.56%. That is a compound annual growth rate of 4.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 235.89B | 14.77% |
Dec 30, 2024 | 205.53B | -26.92% |
Dec 28, 2023 | 281.26B | -19.64% |
Dec 29, 2022 | 349.98B | -31.46% |
Dec 30, 2021 | 510.66B | -57.37% |
Dec 30, 2020 | 1,197.90B | 191.80% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.31T |
Celltrion | 37.23T |
ALTEOGEN | 25.41T |
Yuhan | 8,902.27B |
SK Biopharmaceuticals | 8,551.81B |
Peptron | 7,070.75B |
PharmaResearch | 6,545.48B |
ABL Bio | 5,621.23B |